Skip to main content

Page last checked

Wegovy vs Ozempic: what the two labels actually say

Wegovy and Ozempic contain the same drug, semaglutide, from the same maker. What separates them is what each label approves and how high each one goes.

Source: Read from both FDA labels on DailyMed

What matters first

Label differences
7 of 11 comparison rows differ
Wegovy
Semaglutide
Ozempic
Semaglutide
Direct trial
None published

Medically reviewed by Jennifer Montecillo, MD · non-practicing medical reviewerReviewed 2026-08-12every number here is sourced

Wegovy and Ozempic, line by line

Of the 11 lines below, 4 are identical on both labels and 7 are not. The identical ones are kept in, because they are most of the answer.

Wegovy and Ozempic compared line by line, from both FDA labels
QuestionWegovyOzempic
What is in itSame on both labelsSemaglutideSemaglutide
Who makes itSame on both labelsNovo NordiskNovo Nordisk
How oftenSame on both labelsOnce a weekOnce a week
What the label approvesWeight reduction, heart risk reduction with excess weight, MASH liver disease, and patients from age 12Blood sugar in type 2 diabetes, heart risk reduction in type 2 diabetes, and kidney decline in type 2 diabetes
Starting doseSame on both labels0.25 mg once a week0.25 mg once a week
Top dose2.4 mg, or 7.2 mg for weight reduction in adults2 mg
Doses you can stay on1.7, 2.4 or 7.2 mg0.5, 1 or 2 mg
How a missed week is handledTake it if the next dose is more than 2 days off, otherwise skipTake it within 5 days, otherwise skip
Youngest patient coveredAge 12Adults only
Is there a pillYes, a tablet at 1.5, 4, 9 and 25 mg, under a separate applicationNo. Novo Nordisk sells oral semaglutide for diabetes under a different brand
What the label reports for nausea44 in 100 at 2.4 mg, against 16 on placebo20.3 in 100 at 1 mg, against 6.1 on placebo

Has anyone tested Wegovy against Ozempic directly?

No, and there is no reason anyone would. A trial pitting a drug against itself under two brand names would have nothing to measure.

Trials of semaglutide exist in numbers, and both labels are built on them. What none of them does is compare the two products, because the products are the same substance. Any page claiming one beat the other in a trial is describing something that has not happened.

5Comparison detailsLabel interpretation, alternate phrasing, and product handoffs

Why the nausea figures look so far apart

44 against 20.3 is more than two to one, for the same drug substance. None of that gap is the molecule.

Three things produce it. Wegovy’s table comes from weight trials carried to 2.4 mg; Ozempic’s comes from diabetes trials that stopped at 1 mg. The people were different — adults being treated for obesity against adults who had lived with type 2 diabetes for around nine years. And the two labels print at different cut-offs, 2 in 100 for Wegovy and 5 in 100 for Ozempic.

Both labels open their tables with the warning that rates from one drug’s trials cannot be set against another’s. It applies to this pair even though the drug is the same.

The dose ceiling is the difference that changes what happens

Ozempic stops at 2 mg a week. Wegovy runs to 2.4 mg, and since March 2026 to 7.2 mg for weight reduction in adults.

So the two products do not overlap at the top of their ranges at all. A person on the highest Ozempic dose is below the recommended Wegovy maintenance dose.

Neither label lets you count them as interchangeable

The Wegovy label says not to use it alongside another semaglutide product, or any other GLP-1 receptor agonist. That rules out taking both.

It also means a switch is a switch, not a top-up. The schedules restart differently, because the two products do not share a set of maintenance doses.

What about “Ozempic vs Wegovy”?

It is the same comparison with the names reversed, so both searches lead to this answer.

Publishing both orderings would mean two near-identical pages competing with each other for one answer. We publish one page per pair and let both phrasings land on it.

The full label for each

Compare the products here, then open each product’s own dose schedule and side-effect table for the details.

Wegovy

The Wegovy dose schedule in fullWegovy side effects, dose by doseStoring Wegovy safely

Ozempic

The Ozempic dose schedule in fullOzempic side effects, dose by doseStoring Ozempic safely

Questions readers ask

Can I lose 20 pounds in 3 months on Wegovy?

No published trial answers that. The measured figure is a 72-week average, and at 12 weeks the labeled schedule has not yet reached 2.4 mg.

A trial average also describes a group. Half the people in it did better than the number and half did worse, and the report does not say who.

Which is better for weight loss, Ozempic or Wegovy?

Only Wegovy is approved for weight. Ozempic is the same drug substance approved for blood sugar in type 2 diabetes, and its label stops at 2 mg.

Wegovy runs to 2.4 mg, and to 7.2 mg for weight reduction in adults. So the two are not two options for one job.

What is the downside of Wegovy?

The label’s most common one is nausea, at 44 in every 100 adults on 2.4 mg against 16 on placebo. Diarrhea, vomiting and constipation all land above 20.

The 7.2 mg dose adds something the lower ones barely show: odd skin sensations in 22 of every 100 people, against 6 on 2.4 mg.

Why are people stopping Wegovy?

No reliable survey ranks the reasons. The available numbers are the label’s count of trial withdrawals and FDA side-effect reports.

One figure is concrete. Of those who got odd skin sensations on 7.2 mg, 2 in 100 stopped for good, 8 paused and 23 cut back.

14primary sources, each with the day we read it — open the documents used on this page

Wegovy and Ozempic are registered trademarks of their manufacturers. This page is not written, reviewed or endorsed by them. It reports what two public FDA labels state, and it is not medical advice. It also does not cover price or insurance coverage, which change too often to publish responsibly here.